Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial

IMPORTANCE: The benefit of daily over thrice-weekly antituberculosis therapy among HIV-positive patients with pulmonary tuberculosis (TB) who are receiving antiretroviral therapy remains unproven. OBJECTIVE: To compare the efficacy and safety of daily, part-daily, and intermittent antituberculosis t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Intern Med
Main Authors: Gopalan, Narendran, Santhanakrishnan, Ramesh Kumar, Palaniappan, Alangudi Natarajan, Menon, Pradeep Aravindan, Lakshman, Sekar, Chandrasekaran, Padmapriyadarsini, Sivaramakrishnan, Gomathi Narayan, Reddy, Devarajulu, Kannabiran, Bhavani Perumal, Agiboth, Hemanth Kumar Kupparam, Krishnamoorthy, Vijay, Rathinam, Sridhar, Chockalingam, Chandrasekar, Manoharan, Tamizhselvan, Ayyamperumal, MahilMaran, Jayanthi, Nalini, Satagopan, Kumar, Narayanan, Ravichandran, Krishnaraja, Raja, Sathiyavelu, Sekar, Kesavamurthy, Bhanu, Suresh, Chandra, Selvachitiram, Murugesan, Arasan, Gunasundari, Susaimuthu, Stella, Rathinam, Prabhakaran, Angamuthu, Prabhakar, Jayabal, Lavanya, Murali, Lakshmi, Ramachandran, Ranjani, Tripathy, Srikanth Prasad, Swaminathan, Soumya
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2018
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885164/
https://ncbi.nlm.nih.gov/pubmed/29507938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2018.0141
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados